Article

Antihyperglycemic and hypolipidemic effects of Costus speciosus in alloxan induced diabetic rats.

Department of Biosciences, Sardar Patel University, Vallabh Vidyanagar-388120, Gujarat, India.
Phytotherapy Research (Impact Factor: 2.4). 06/2008; 22(5):620-6. DOI: 10.1002/ptr.2302
Source: PubMed

ABSTRACT Hyperglycemia, abnormal lipid and antioxidant profiles are the most usual complications in diabetes mellitus. In the present study, the antihyperglycemic, antihyperlipemic and antioxidant potency of an ethanol extract of Costus speciosus root was investigated in alloxan-induced diabetic male (Charles Foster) rats. Four groups of alloxan diabetic rats (n = 6) were administered orally with different doses of Costus speciosus root extract (150, 300 and 450 mg/kg BW) and a standard drug, glibenclamide (600 microg/kg BW), for 4 weeks. Two groups of rats (n = 6) served as normal and diabetic controls. While the diabetic controls showed significant abnormal carbohydrate, lipid and antioxidant profiles, administration of 150 mg/kg BW dose neither improved glucose nor lipid metabolism and antioxidant levels. Administration of 300 and 450 mg/kg BW doses, however, resulted in a reversal of diabetes and its complications. Both doses significantly brought down blood glucose concentration (26.76%, 34.68%), increased glycogenesis and decreased glyconeogenesis bringing the glucose metabolism toward normalcy. These doses also reversed the hyperlipidemia by reducing plasma total lipid (12.87%, 178.24%), cholesterol (21.92%, 30.77%) and triglyceride (25.32%, 33.99%) and improved hepatic antioxidant enzyme activities. The high dose (450 mg/kg BW) was found to have more potential antioxidant activities compared with glibenclamide. It is concluded that Costus speciosus root extract possesses anti-hyperglycemic, antihyperlipemic and antioxidative effects, which may prove to be of clinical importance in the management of diabetes and its complications.

0 Bookmarks
 · 
167 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sixty Egyptian buffalo heifers ageing about one year old, with an average weight of about 250 to 260 kg were allotted randomly according to their live body weight and age into three equal groups; Group I which received a basal ration; Group II which received a basal ration with fine ground Costus speciosus roots in a concentration of 2.5 kg/ton ration and Group III which received a basal ration with fine ground C. speciosus roots in a concentration of 5 kg/ton ration. Blood samples were collected from each group and divided into two blood samples, one for serum separation and the other for hematological study. Separated serum samples were subjected to the biochemical analysis of glucose, cholesterol, aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, urea, uric acid and electrophoretic pattern. The obtained data revealed a decrease in serum glucose and cholesterol levels which may be utilized in anabolic pathways during this period. While total protein, albumin, α 1 -globulin, β-globulin, hemoglobin, packed cell volume (PCV) and lymphocytes were significantly increased especially in Group III. In addition, the erythrocytes antioxidant status was significantly improved by C. speciosus supplementation. We could conclude that supplementation of C. speciosus powder to the Egyptian buffalo heifers improves the health status, total antioxidant capacity and hematology. So, we advise owners to add C. speciosus ground powder to the ration of heifers.
    African journal of pharmacy and pharmacology 11/2013; 7:2774-2779. · 0.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of chronic illnesses has increased worldwide. Diabetes is one such illness and 80% of the diabetic population lives in the developing world. There is a rapidly growing trend towards the use of Complementary and Alternative Medical practices in Diabetes. Sri Lanka is a developing Asian nation with a rich culture of Ayurvedic and native medical culture.The objective of this study was to find the prevalence of use of CAMs in a diabetic population attending a large multiethnic diabetes facility in a University unit and to assess whether there is an increase in the incidence of hypoglycaemic episodes among users of CAMs.
    BMC Complementary and Alternative Medicine 10/2014; 14(1):374. · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the mechanisms of the anti-hyperglycemic effect of Costus speciosus (C. speciosus) root ethanolic extracts (CSREt) by assessing its action on insulin synthesis and glucose catabolic enzyme gene expression and activities in streptozotocin (STZ) diabetic rats. This study was carried out at the Biochemical Laboratory, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt between July and August 2013. Sixty male albino rats (120 +/- 20 g weight, and 6 months old) were used and divided into 6 groups (n=10). Two groups served as diabetic and nondiabetic controls. Four groups of STZ diabetic animals were given oral C. speciosus (CSREt) in doses of 200, 400, and 600 mg/kg body weight, and 600 µg/kg body weight of the standard drug glibenclamide for 4 weeks. The CSREt 400 and 600 mg/kg body weight induced a decrease in blood glucose and an increase in serum insulin level, glucokinase (GK), aldolase, pyruvate kinase (PK), succinate dehydrogenase (SDH), and glycogen synthase activities in addition to a higher expression level of insulin, insulin receptor A (IRA), GK, PK, SDH, and glucose transporting protein. The C. speciosus has anti-hyperglycemic activity. It induces insulin secretion and release from cells, as well as stimulates the tissue's insulin sensitivity leading to an increase of the tissues' glucose uptake, storage, and oxidation.
    Saudi medical journal 12/2014; 35(12):1501-6. · 0.55 Impact Factor